Watch the Demo
Learn how to use the Strep A 2 test by watching this product demonstration.
global Point Of Care
ID NOW™
Confidence that Cares.
Rapid, Molecular Results at the Point of Care
The ID NOW™ rapid molecular platform uniquely combines speed, accuracy, and ease of use to get confident answers to relevant diagnostic questions - helping improve point of care testing for a more efficient patient care experience.
For in vitro Diagnostic Use.
Confidence that Cares.
Rapid, Molecular Results at the Point of Care
The ID NOW™ rapid molecular platform uniquely combines speed, accuracy, and ease of use to get confident answers to relevant diagnostic questions - helping improve point of care testing for a more efficient patient care experience.
For in vitro Diagnostic Use.
Benefits
Provide Better Care for Patients
- Helps ensure more patients receive specific Flu, Covid, or Strep treatment
- Supports reduction of unnecessary antibiotics complications and follow-ups Improve Efficiency
- Provide results during the patient interaction to shorten visits and improve workflows
- Helps reduce need for confirmatory testing
- Reduce manual work and potential for transcription errors with EMR/Middleware connectivity
Increase Patient and Clinician Satisfaction
- Supports clinician confidence and reduced patient wait time
Support Diagnostic Stewardship:
Providing the Right Test to the Right Patients
- Gives clinicians flexibility to test only for relevant diseases based on seasonality, patient risk profile, etc.
SIMPLE AND SECURE RESULTS REPORTING
Track, consolidate and report ID NOW™ test results from multiple decentralized instruments and locations using AegisPOC™.
Illuminating Insights: Rapid Molecular Testing for Respiratory Disease
Rapid molecular testing is an important tool in the fight against respiratory infectious disease. The ID NOW™ platform can lead to faster diagnosis and better overall patient care.
ID NOW™ is significantly faster than other molecular methods and more accurate than conventional rapid tests.
Helpful Documents
PRODUCT DOCUMENTS
PRODUCT CODE
| ID NOW™ System | Code |
|---|---|
| ID NOW™ Instrument | NAT-000 (Global) |
| ID NOW™ COVID-19 2.0 Test Kit | 193-000 |
| ID NOW™ COVID-19 2.0 Control Kit (12 positive, 12 blank swabs) | 192-080 |
| ID NOW™ Influenza A & B 2 24 Test Kit | 427-000 (Global) |
| ID NOW™ Influenza A & B Control Swab Kit | 425-080 (Global) |
| ID NOW™ Strep A 2 24 Test Kit | 734-000 (Global) |
| ID NOW™ Strep A 2 Control Swab Kit | 734-080 (Global) |
| ID NOW™ RSV 24 Test Kit | 435-000 (Global) |
| ID NOW™ RSV Control Swab Kit | 435-080 (Global) |
| COVID-19 Swab Transport Tube Accessory Pack 24 Count | 190-010 |
| ID NOW™ Barcode Scanner | OPR2001ZWU1-201 (Global) |
| Universal Printer | 55115 (Global) |
| IDNOWPRINT |
Videos
Watch the Technology Video
Learn how Abbott utilizes unique isothermal nucleic acid amplification technology.
View References
- Bonner, A.B. et al. (2003) Impact of the Rapid Diagnosis of Influenza on Physician Decision-Making and Patient Management in the Pediatric Emergency Department: Results of a Randomized, Prospective, Controlled Trial. Pediatrics Vol. 112 No. 2.
